Patent ID: 7332631
Filing Date: 2008-02-19
Classification: A61P,C07C,C07D,C07K

Abstract:
1. A method for treating an autoimmune disease involving Fc receptor activity comprising administering to a subject in need of treatment one or more compounds having the general formula II: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are each independently selected from H, halogen, NO R18, R19 are each independently selected from H, C R20, R21 are each independently selected from H, C R11, R12 are each independently selected from H, C and wherein the autoimmune disease is selected from the group consisting of rheumatoid arthritis, immune thrombocytopenia purpura, systemic lupus erythematosus and Crohn's disease.